Vimal Mehta - CEO and President, Director at BioXcel Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO and President, Director
Issuer Symbol
BTAI on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Vimal Mehta since 05 Jan 2025

Holdings reported by Vimal Mehta for BioXcel Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 480,343 $999,113 $2.08 14 Dec 2025 By BioXcel LLC
Common Stock 20,876 $43,422 $2.08 15 Dec 2025 Direct
Restricted Stock Units 1,751 $848 $0.3523 15 Dec 2025 Direct Common Stock
Common Stock 125 $260 $2.08 14 Dec 2025 By Spouse
Stock Option (right to buy) 660,000 07 Jan 2025 Direct Common Stock

Transactions reported by Vimal Mehta for BioXcel Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.